Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Standard oral glutathione shows only 0.7% bioavailability due to gastrointestinal degradation
Based on this multifaceted activity, the authors proposed GHK-Cu as a promising therapeutic candidate to help prevent or slow age-associated neurodegenerative disorders and cognitive decline, positioning it as a potential epigenetic and regenerative agent rather than a single-target drug
Practical Impact on Product Development The odorless nature of SAG brings great flexibility to product development
Injectable peptide therapy helps restore these declining regenerative signals
It is intended solely for laboratory research by trained professionals in certified environments.
GHK-Cu may support tissue repair and recovery by regulating inflammatory pathways and promoting healthy cellular turnover
US$ 24.47
US$ 24.03
US$ 29.22
